Adaptive Biotechnologies
ADPT
ADPT
190 hedge funds and large institutions have $457M invested in Adaptive Biotechnologies in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 56 increasing their positions, 69 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
190
Holders Change
-10
Holders Change %
-5%
% of All Funds
2.75%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
56
Reduced
69
Closed
37
Calls
$12K
Puts
$581K
Net Calls
-$569K
Net Calls Change
-$341K
Top Buyers
| 1 |
RCMNY
1
Rubric Capital Management (New York)
New York
|
$33.7M |
| 2 |
2
Millennium Management
New York
|
$2.68M |
| 3 |
3
Ameriprise
Minneapolis,
Minnesota
|
$2.72M |
| 4 |
4
Cerity Partners
New York
|
$2.17M |
| 5 |
5
Bank of America
Charlotte,
North Carolina
|
$1.66M |
